Related Articles
Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer Corrigendum in /10.3892/ol.2021.12772
Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts
Comparison of cost-effectiveness of regorafenib and trifluridine/tipiracil combination tablet for treating advanced and recurrent colorectal cancer
Regression of human colon cancer xenografts in SCID mice following oral administration of water-insoluble camptothecins
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells